High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasiaHironori Harada, Toshiya Inaba, Taiichi Kyo et al.|Blood|2003Cited by 277
Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutationsHiromasa Niimi, A Kimura, Jun Imagawa et al.|Leukemia|2006Cited by 67
Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemiaMoe Kadono, Hirotaka Matsui, Akinori Kanai et al.|Experimental Hematology|2016Cited by 66
Treatment Results and Malignant Complications in Patients on Long-Term Treatment with Tyrosine Kinase Inhibitors(TKIs) for Chronic Myeloid Leukemia(CML)Taiichi Kyo, Keiko Ohtani, Hideki Asaoku et al.|Blood|2012Cited by 1
t(8;21)-Positive AML with Mutant Kit Is a Novel Therapeutic Target of Imatinib Mesylate.Hiroya Asou, Toshiya Inaba, Taiichi Kyo|Blood|2004Cited by 0